Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Spinosyn-d
1. Spinosad Factor D
2. 131929-63-0
3. A 83543d
4. Chebi:9232
5. 78g4631rtt
6. (1s,2s,5r,7s,9s,10s,14r,15s,19s)-15-[(2r,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-19-ethyl-4,14-dimethyl-7-[(2r,3r,4r,5s,6s)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione
7. (2s,3ar,5as,5bs,9s,13s,14r,16as,16bs)-13-{[(2r,5s,6r)-5-(dimethylamino)-6-methyltetrahydro-2h-pyran-2-yl]oxy}-9-ethyl-4,14-dimethyl-7,15-dioxo-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-1h-as-indaceno[3,2-d]oxacyclododecin-2-yl 6-deoxy-2,3,4-tri-o-methyl-alpha-l-mannopyranoside
8. 1h-as-indaceno3,2-doxacyclododecin-7,15-dione, 2-(6-deoxy-2,3,4-tri-o-methyl-.alpha.-l-mannopyranosyl)oxy-13-(2r,5s,6r)-5-(dimethylamino)tetrahydro-6-methyl-2h-pyran-2-yloxy-9-ethyl-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-4,14-dimethyl-, (2
9. Spinosad Factor D [usan]
10. Unii-78g4631rtt
11. Spinosyn D [mi]
12. Schembl465825
13. Chembl503450
14. Dtxsid3037599
15. Zinc85537011
16. 1h-as-indaceno(3,2-d)oxacyclododecin-7,15-dione, 2-((6-deoxy-2,3,4-tri-o-methyl-alpha-l-mannopyranosyl)oxy)-13-(((2r,5s,6r)-5-(dimethylamino)tetrahydro-6-methyl-2h-pyran-2-yl)oxy)-9-ethyl-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-4,14-dimet
17. Xs175291
18. J-006090
19. Q27108325
20. (2r,3as,5ar,5bs,9s,13s,14r,16as,16br)-2-((6-deoxy-2,3,4-tri-o-methyl-alpha-l-mannopyranosyl)oxy)-13-(((2r,5s,6r)-5-(dimethylamino)tetrahydro-6-methyl-2h-pyran-2-yl)oxy)-9-ethyl-4,14-dimethyl-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-1h-as-indaceno(3,2-d)oxacyclododecin-7,15-dione
21. 1h-as-indaceno(3,2-d)oxacyclododecin-7,15-dione, 2-((6-deoxy-2,3,4-tri-o- Methyl-a-l-mannopyranosyl)oxy)-13-(((2r,5s,6r)-5- (dimethylamino)tetrahydro-6-methyl-2h-pyran-2-yl)oxy)-9-ethyl- 2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-4,14-dimethyl-, (2s,3ar,5as,5bs,9s,13s,14r,16as,16bs)-
22. 1h-as-indaceno(3,2-d)oxacyclododecin-7,15-dione, 2-((6-deoxy-2,3,4-tri-o-methyl-alpha-l-mannopyranosyl)oxy)-13-(((2r,5s,6r)-5-(dimethylamino)tetrahydro-6-methyl-2h-pyran-2-yl)oxy)-9-ethyl-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-4,14-dimethyl-, (2s,3ar,5as,5bs,9s,13s,14r,16as,16bs)-
Molecular Weight | 746.0 g/mol |
---|---|
Molecular Formula | C42H67NO10 |
XLogP3 | 4.8 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 9 |
Exact Mass | 745.47649733 g/mol |
Monoisotopic Mass | 745.47649733 g/mol |
Topological Polar Surface Area | 111 Ų |
Heavy Atom Count | 53 |
Formal Charge | 0 |
Complexity | 1330 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 17 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Spinosyn D manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Spinosyn D, including repackagers and relabelers. The FDA regulates Spinosyn D manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Spinosyn D API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Spinosyn D manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Spinosyn D supplier is an individual or a company that provides Spinosyn D active pharmaceutical ingredient (API) or Spinosyn D finished formulations upon request. The Spinosyn D suppliers may include Spinosyn D API manufacturers, exporters, distributors and traders.
click here to find a list of Spinosyn D suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Spinosyn D DMF (Drug Master File) is a document detailing the whole manufacturing process of Spinosyn D active pharmaceutical ingredient (API) in detail. Different forms of Spinosyn D DMFs exist exist since differing nations have different regulations, such as Spinosyn D USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Spinosyn D DMF submitted to regulatory agencies in the US is known as a USDMF. Spinosyn D USDMF includes data on Spinosyn D's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Spinosyn D USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Spinosyn D suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Spinosyn D as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Spinosyn D API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Spinosyn D as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Spinosyn D and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Spinosyn D NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Spinosyn D suppliers with NDC on PharmaCompass.
Spinosyn D Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Spinosyn D GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Spinosyn D GMP manufacturer or Spinosyn D GMP API supplier for your needs.
A Spinosyn D CoA (Certificate of Analysis) is a formal document that attests to Spinosyn D's compliance with Spinosyn D specifications and serves as a tool for batch-level quality control.
Spinosyn D CoA mostly includes findings from lab analyses of a specific batch. For each Spinosyn D CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Spinosyn D may be tested according to a variety of international standards, such as European Pharmacopoeia (Spinosyn D EP), Spinosyn D JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Spinosyn D USP).
LOOKING FOR A SUPPLIER?